Highly Sensitive Tissue-free ctDNA Detection for MRD & Response Monitoring
Time: 9:30 am
day: Day One
Details:
- Overcoming challenges of today’s MRD and monitoring tests
- New data showing high sensitivity with epigenomics-based MRD and response monitoring
- Uncovering novel predictions of response to therapy to better stratify patients
